9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology

Abstract

The proceedings contain 307 papers. The special focus in this conference is on child and adolescent psychopharmacology. The topics include: Interpersonal psychotherapy (IPT) in the perinatal context; complementary medicine in antidepressant treatment; type of traumatic experience and depression in adolescents; neuroprotective properties of the sigma-1 ligand afobazole; novel antiparkinsonian and neuroprotective drug hemantane; smoking and beyond in schizophrenia patients; coping with adherence problems in longterm psychiatric treatments; code of ethics, obligations and specific points in the perinatal psychiatry; impact of maternal treatments on the infant during the perinatal period symposium of the Marce society; correction of astenoadinamic option of post abstinence disorders; psychiatry and psychopharmacotherapy in post-soviet space; irrational use of antipsychotic drugs as one of the problems of emotional burnout syndrome; pharmacogenomics of treatment response in depression; neuroimaging as a tool to observe impact of CYP2D6 on neural activation in humans; therapeutic interventions and oxidative stress markers in bipolar disorder; synaptic and intracellular signaling pathway dysfunctions in depression; hospital-based community psychiatric services in Malaysia; anxiety disorders in pregnancy; the importance of therapeutic drug monitoring in child and adolescent psychiatry; pharmacokinetic, pharmacodynamic and pharmacogenetic approach in the field of child and adolescent psychiatry in Turkey and the world; different approaches for treatment of social anxiety in adolescents; emergency situations in child and adolescent psychiatry and its management; current treatment modalities for tic disorders in children and adolescents; importance of pharmagenetics in the psychiatry of child and adolescent; psychiatric evaluation and follow-up of bariatric surgery patients; classification and epidemiology of eating disorders in the DSM-5; psychopharmacological treatments in eating disorders & comorbid conditions; role of hypothalamic neuropeptides and atypical antipsychotics effects on the regulation of eating behavior; possible mechanisms of atypical antipsychotic induced weight gain and preventive treatment options; properties of antipsychotics in patients with schizophrenia in care centers; rational drug use in schizophrenia; psychosocial rehabilitation for schizophrenia; adherence to treatment in patients with schizophrenia; management of the antidepressants usage risks in children and adolescents; challenges in medical imaging and medical image analysis; from perspective of impulse-eating disorders; impulsivity and psychiatric disorders; obsessive compulsive disorder from the perspective of impulse control disorders; current issues in addiction psychiatry; current issues in inpatient services; current difficulties in forensic psychiatry; personalized medicine in psychiatry; the use of therapeutic drug monitoring (TDM) in psychiatry; psychopharmacological approach to sleep problems with chronic physical diseases; maintenance ECT; treatment update in elimination disorders based on new scientific findings; psychotherapy of sleep disturbances in posttraumatic stress disorder; the role of psychopharmacological drugs in the prevention of suicidal behaviors; frontiers between attention deficit hyperactivity disorder and bipolar disorder; management of substance use disorders; voluntary versus involuntary admissions; resistance and resolutions in adult attention deficit hyperactivity disorder; psychotropic drug use in oncology patients; psychotropic drug use in pregnancy and lactation; pharmacotherapy principles in consultation-liaison psychiatry; drug interactions and psychotropic drug use in organ failures; the future and new horizons of psychopharmacology; factors associated with time to pharmacotherapy in patients with attention-deficit/hyperactivity disorder (ADHD) symptoms in central Europe and East Asia; the effect of dissociation on academic performance and attention processes; the frequency of metabolic syndrome in psychiatric patients taking antidepressant medication; MicroRNAs as potential biomarkers for major depressive disorder; refraction and anterior segment parameters in patients with schizophrenia; exposure to violence in staff members of Sivas Numune hospital; distribution of applications to the patients' rights council of Sivas Numune Hospital and Sivas state Hospital for the last one year; depression, sexual dysfunction and childhood trauma in patients with post traumatic stress disorder; ghrelin-lipid levels in panic disorder before and after treatment and their relationship with agoraphobia; attention deficit hyperactivity disorder at schools in Sfax, Tunisia; investigation of iron deficiency, thyroid function abnormalities and deficiency of folate and vitamin B12 in children with attention deficit hyperactivity disorder; assessment of the effects of antihistaminic drugs on mood, sleep quality, sleepiness, and dream anxiety; effects of electroconvulsive therapy on serum brain-derived neural factor and nerve growth factor in treatment resistant major depression; Efficacy of clozapine in treatment-resistant schizophrenia; relationship of plasma microRNAs with nicotine use and disease status among depressed patients; evaluation of the interrelationships between complaints, diagnoses, and drug usage in an outpatient clinic of pediatric, and adolescent psychiatry; P50 sensory gating in patients with primary vaginismus; association between neutrophil to lymphocyte ratio and severity of depression in patients with depressive disorders; the relationship between weight change and obsessive thoughts in patients with anorexia nervosa; tardive dyskinesia in long term hospitalized patients with schizophrenia; the relationship between antioxidant capacity and attack properties in bipolar disorder patients; factors related with unintentional injuries in attention-deficit/hyperactivity disorder; lithium enhances alpha and beta oscillations in cognitive networks; the relationship between serum levels of haptoglobin and neopterin and the number of episodes in patients with major depression; distinguishing bipolar disorders from psychotic disorders in adolescents and subtleties of indistinguishable cases; the concept of development of mental health services in the republic of Kazakhstan; psychotherapy of sleep disturbances in posttraumatic stress disorder; fluoxetine and aripiprazole treatment for OCD in a child with wolfram syndrome; safety of electroconvulsive therapy in pregnancy; evaluation of criminal responsibility for children between 2005-2009 in Corum; delusional disorder probably induced by bupropion; depression, anxiety and sociodemographic features in first degree female psychiatric outpatient relatives of alcohol abusers; antipsychotic treatment of patients who are recorded in Corum Community Mental Health Center with the diagnosis of psychotic disorders; efficacy and tolerability of aripiprazole on pervasive development disorders; tramadol induced status epilepticus in an old woman with polydrug abuse; evaluation of the "therapeutic window" of GK-2 in intracerebral posttraumatic hematoma model in rats; Autistic spectrum symptoms in subtypes of attention deficit hyperactivity disorder; the psychiatric profile of chronic pruritus patients; night eating syndrome and binge eating disorder in depression; the effect of polycystic ovary syndrome phenotypes on quality of life, depression and anxiety levels; impaired glucose tolerance metabolism after the use of antidepressants; epileptic story and coping attitudes; the relationship between the levels of anxiety and coping attitudes of nurses working at a training hospital; lesion localization and depressive symptoms in patients with multiple sclerosis; frequency of head trauma history in patients with narcolepsy; serum neopterin levels in patients with narcolepsy; physical injury and cortical excitability in patients with posttraumatic stress disorder; clinical severity and neural excitability in posttraumatic stress disorder; aggression and cortical excitability Iin patients with posttraumatic stress disorder; the ratio of the second to fourth fingers (2D:4D) in schizophrenia; relationship between symptom distribution and severity of generalized anxiety disorder (GAD) with gender and marital status; sociodemographic characteristics of patients who admitted to smoking cessation clinic of a university hospital; the role of trauma and dissociation in treatment resistant obsessive compulsive disorder; the relationship between soluble intercellular adhesion molecules and attention deficit hyperactivity disorder; clonidine treatment in a tuberous sclerosis case with behavioral problems associated with mental retardation; complicated grief and depressive disorder among elderly patients who applied to psychiatrists and family physicians; the practice of pharmacological treatment in a child and adolescent psychiatry outpatient clinic; the relationship between mitochondrial complex I-III gene mRNA levels and clinical features of the patients with schizophrenia; hirsutism due to mirtazapine treatment; a probable case of very early onset schizophrenia managed with risperidone; a case of adolescent bipolar disorder presented with catatonic picture; drug induced behavioral disinhibition in children treated with selective serotonin reuptake inhibitors; depression and assessment of the life quality among patients with obstructive sleep apnea syndrome; a case report of sexual dysfunction due to hyperprolactinemia associated with increased dose of paliperidone palmitate injection; restless legs syndrome prevalence and depression-anxiety disorder association in anemic patients; the relationship between sleep quality and nitric oxide in healthy volunteers; factors affecting the quality of sleep in healthy population; aripiprazole treatment combined with methylphenidate in a 46,XY,